期刊文献+

调强适形放疗联合热化疗治疗进展期胃癌34例 被引量:5

IMRT combined thermo-chemotherapy treatment of advanced gastric cancer of 34 cases
下载PDF
导出
摘要 目的:研究调强适形放射治疗(IMRT)联合热、化疗治疗进展期胃癌的临床疗效。方法:对85例进展期胃癌患者采用方差分析单纯采用IMRT与联合热疗、联合热化疗的差异,并分析放疗量效之间的关系、微波热疗次数与疗效的关系。结果:单纯IMRT治疗有效率为47.62%,IMRT联合热疗有效率为56.67%,IMRT联合热、化疗有效率为73.53%;放射治疗量DT<40Gy有效率为56.00%,DT40~60Gy有效率为62.68%,DT≥60Gy有效率为72.41%;微波热疗<4次有效率为46.67%;微波热疗≥4次有效率为76.48%。经统计学处理,IMRT联合热化疗治疗组比单纯IMRT组有效率明显提高,差异有显著性(P<0.05);IMRT联合热疗组比单纯IMRT组有效率有所提高,但两组之间差异无显著性(P>0.05);DT为≥60Gy组比DT<40组有效率明显提高,差异有显著性(P<0.05);DT为40~60Gy组比DT<40组有效率有所提高,但两组之间差异无显著性(P>0.05)。结论:IMRT联合热、化疗能更有效的控制进展期胃癌发展;一定条件下,放射剂量越高治疗效果越好;在病人身体能耐受的前提下,微波热疗次数与疗效呈正相关。 Objective:To study the intensity modulated radiation therapy IMRT combined heat and chemotherapy treatment of advanced gastric cancer. Methods:85 cases of advanced gastric cancer treated with IMRT using a simple analysis of variance with the Joint hyperthermia, chemotherapy combined thermal differences and analysis of radiation dose-effect relationship between the frequency of microwave hyperthermia and the relationship between efficacy. Results:IMRT treatment efficiency was 47. 62%, tMRT combined heat treatment efficiency was 56.67%, IMRT combined heat and chemotherapy response rate was 73.53% ; radiation therapy volume DT〈40Gy efficiency was 56.00%, DT40 - 60Gy efficiency was 62.68%, DT ≥ 60Gy to 72. 41% efficient; microwave hyperthermia 〈4 times the effective rate was 46.67%; microwave hyperthermia ≥ 4 times the effective rate was 76. 48%. Statistical analysis, IMRT combined thermo-chemotherapy treatment group than simple group efficient IMRT significantly improved, there was significant difference (P〈0. 05); IMRT combined therapy group than the simple efficiency of IMRT group has increased, but between the two groups There was no significant difference (P〉0.05) ; DT group ≥ 60Gy for DT 〈40 group was markedly improved, there was significant difference (P〈0.05); DT for 40 - 60Gy group DT 〈40 group efficiency increased, but the difference between the two groups was not significant (P〉0. 05). Conclusion: IMRT combined heat and chemotherapy can more effectively control the development of advanced gastric cancer; certain conditions, the higher the treatment dose, the better; in the patient's body can tolerate, under the premise of the number of microwave hyperthermia was positively correlated with the effect.
出处 《陕西医学杂志》 CAS 2010年第2期160-162,共3页 Shaanxi Medical Journal
基金 全军科技攻关计划基金资助项目(06G034)
关键词 胃肿瘤/治疗 药物疗法 @热疗 @调强适形放射治疗 Stomach neoplasms/therapy Drug therapy @Hyperthermia @IMRT
  • 相关文献

参考文献11

二级参考文献63

共引文献58

同被引文献72

  • 1冯莉,刘巍,洪雷,吕雅蕾,王玉栋,左静,王龙,韩晶,单玉洁.化疗联合局部热疗治疗晚期胃癌疗效与安全性的Meta分析[J].转化医学杂志,2014,3(2):84-87. 被引量:7
  • 2亓久德,玄菲,任刚,郭本成.全身热疗联合化疗治疗晚期胃癌17例疗效观察[J].山东医药,2007,47(2):58-58. 被引量:3
  • 3李新娉,虞喜豪,武文森,周建梁.大功率微波全身热疗与化疗联合应用治疗晚期肿瘤的临床观察[J].肿瘤,2007,27(1):67-69. 被引量:9
  • 4Santambrogio R, Costa M, Barabino M, et al. Recurrent hepatocel- lular carcinoma successfully treated with laparoscopic thermal ab- lation [ J ]. Surg Endosc ,2012,26 (4) : 1108-1115.
  • 5Ried M, Potzger T, Braune N, et al. Cytoreductive surgery and hy- perthermic intrathoracic chemotherapy perfusion for malignant pleural tumours: perioperative management and clinical experi- ence [ J ]. Eur J Cardiothorac Surg, 2013,43 ( 4 ) : 801-807.
  • 6Saeki H, Ohga T, Ito S, et al. Evaluation of muhi-modality treat- ment for the patients with advanced esophageal cancer[ J]. Fuku- oka lgaku Zasshi ,2002,93 (12) :259-265.
  • 7Deng N, Goh LK, Wang H, et al. A comprehensive survey of ge- nomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeu- tic targets[J]. Gut,2012,61 (5) :673-684.
  • 8Bang YJ, Van Cutsem E, Feyereislova A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophage- al junction cancer ( ToGA ) : a phase 3, open-label, randomised controlled trial[J]. Lancet,2010,376(9742) :687-697.
  • 9Oshima Y ,Tanaka 14, Murakami H, et al. Lapatinib sensitivities of two novel trastuzumab-resistant HER2 gene-amplified gastric cancer cell lines [ J ]. Gastric Cancer,2014,17 (3) :450-462.
  • 10Bystricky B, Okines AF, Cunningham D. Optimal therapeutic strat- egies for resectable oesophageal or oesophagogastric junction cancer [ J 1. Drugs ,2011,71 ( 5 ) :541-555.

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部